MedPath

National Heart, Lung, and Blood Institute

National Heart, Lung, and Blood Institute logo
๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Collection of Heart Tissue Sample During Open Heart Surgery

Completed
Conditions
Ischemia
First Posted Date
2007-01-18
Last Posted Date
2017-07-02
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00423553
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Suburban Hospital, Bethesda, Maryland, United States

Effectiveness of Etanercept for Idiopathic Pneumonia Syndrome Following Stem Cell Transplantation (BMT CTN 0403)

Phase 3
Completed
Conditions
Idiopathic Pneumonia Syndrome
Pneumonia
Interventions
Drug: Placebo plus corticosteroid
First Posted Date
2007-01-11
Last Posted Date
2021-11-01
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
37
Registration Number
NCT00421174
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Florida College of Medicine (Shands), Gainesville, Florida, United States

๐Ÿ‡บ๐Ÿ‡ธ

Johns Hopkins University, Baltimore, Maryland, United States

๐Ÿ‡บ๐Ÿ‡ธ

Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 9 locations

Validation of MRI Measurement of Cardiac Blood Flow

Completed
Conditions
Coronary Artery Disease
First Posted Date
2007-01-04
Last Posted Date
2017-07-02
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
34
Registration Number
NCT00417625
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Rilonacept to Improve Artery Function in Patients With Atherosclerosis

Phase 2
Completed
Conditions
Coronary Artery Disease
Inflammation
Atherosclerosis
Endothelial Dysfunction
Interventions
Drug: Placebo
First Posted Date
2007-01-01
Last Posted Date
2012-04-30
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
10
Registration Number
NCT00417417
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Factors Associated With Coronary Heart Disease in African Americans in the Jackson Heart Study

Completed
Conditions
Coronary Disease
Cardiovascular Diseases
First Posted Date
2006-12-22
Last Posted Date
2016-07-29
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
5302
Registration Number
NCT00415415
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Jackson Heart Study, Jackson, Mississippi, United States

Role of p53 Gene in Metabolism Regulation in Patients With Li-Fraumeni Syndrome

Completed
Conditions
Li-Fraumeni Syndrome
Mitochondrial Disorders
Carriers of p53 Mutation
First Posted Date
2006-12-04
Last Posted Date
2021-11-22
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
82
Registration Number
NCT00406445
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Increasing Physical Activity as Part of a Smoking Cessation Program

Not Applicable
Completed
Conditions
Smoking Cessation
First Posted Date
2006-11-23
Last Posted Date
2008-07-02
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
400
Registration Number
NCT00403312
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, United States

๐Ÿ‡บ๐Ÿ‡ธ

University of Memphis Center for Community Health, Memphis, Tennessee, United States

Dexamethasone to Prevent Oral Chronic Graft-versus-Host Disease

Phase 2
Completed
Conditions
Graft vs Host Disease
Interventions
First Posted Date
2006-10-23
Last Posted Date
2022-02-10
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
62
Registration Number
NCT00391170
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Effectiveness of Combining Light and Non-Light Treatments for Jet Lag and Sleep Disorders

Not Applicable
Conditions
Sleep Disorders, Circadian Rhythm
Interventions
Procedure: Light Therapy
Drug: Methylxanthine
First Posted Date
2006-10-12
Last Posted Date
2009-08-25
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
48
Registration Number
NCT00387179
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Sleep and Chronobiology Laboratory, Boulder, Colorado, United States

Catheter-Based Treatment of Cardiovascular Disease

Not Applicable
Completed
Conditions
Structural Heart Disease
Obstructive Peripheral Artery Disease
Obstructive Coronary Artery Disease
First Posted Date
2006-09-25
Last Posted Date
2017-07-02
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
150
Registration Number
NCT00380016
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Heart, Lung and Blood Institute (NHLBI), 9000 Rockville Pike, Bethesda, Maryland, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath